Phosphodiesterase regulation of nitric oxide signaling

Keyphrases

• Phosphodiesterase 100%
• Nitric Oxide Signaling 100%
• Cyclic GMP 66%
• Phosphodiesterase Type 5 Inhibitors 33%
• PDE1 33%
• Disease States 16%
• Catecholamines 16%
• Myocytes 16%
• Cardiovascular System 16%
• Disease Conditions 16%
• Evidence Support 16%
• Chronic Disease 16%
• Heart Failure 16%
• Vascular Smooth muscle Cells 16%
• Hydrolysis 16%
• PDE2 16%
• Synthetic Pathway 16%
• Catabolic 16%
• Angiotensin 16%
• PDE5 Inhibitors 16%
• Protein Kinase G 16%
• NO-cGMP 16%
• Nitrate 16%
• Drug Tolerance 16%
• Cardiac Pathophysiology 16%
• Distal Effects 16%
• Vascular Pathology 16%
• Long-term Exposure 16%
• Selective Interaction 16%
• Load Stress 16%
• Pressure Load 16%
• Support-significant 16%
• Nitric Oxide Regulation 16%
• Stress Failure 16%

Biochemistry, Genetics and Molecular Biology

• Nitric Oxide 100%
• Phosphodiesterase 100%
• PDE1 33%
• Upregulation 16%
• Angiotensin 16%
• Cardiac Muscle Cell 16%
• Agonist 16%
• Enzymatic Hydrolysis 16%
• Catecholamine 16%
• CGMP-dependent Protein Kinase 16%
• Drug Tolerance 16%